The molecular pathogenesis of pancreatic cancer: Clarifying a complex circuitry

Genes and Development

Volumn 20, Issue 22, 2006, Pages 3049-3053

  Rustgi, Anil K ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MYC PROTEIN; NOTCH RECEPTOR; SMAD4 PROTEIN; SONIC HEDGEHOG PROTEIN; TRANSCRIPTION FACTOR PDX 1; TRANSFORMING GROWTH FACTOR BETA; WNT PROTEIN;

ANGIOGENESIS; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER IMMUNOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CELL DIFFERENTIATION; CELL PROLIFERATION; CYSTADENOCARCINOMA; GENE EXPRESSION; GENE THERAPY; HUMAN; INTRADUCTAL PAPILLARY MUCINOUS TUMOR; NONHUMAN; ONCOGENE; ONCOGENE H RAS; ONCOGENE K RAS; ONCOGENE RAS; PANCREAS ADENOCARCINOMA; PANCREAS CANCER; PANCREAS DUCT; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; TUMOR SUPPRESSOR GENE;

ANIMALS; CARCINOMA, PANCREATIC DUCTAL; GENES, TUMOR SUPPRESSOR; MICE; PANCREATIC NEOPLASMS; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA;

EID: 33751216840     PISSN: 08909369     EISSN: 15495477     Source Type: Journal    
DOI: 10.1101/gad.1501106     Document Type: Review

References (33)

1. Adsay, N.V. 2005. Pathological classification of cystic neoplasms of the pancreas. In Pancreatic cancer (eds. D.D. Von Hoff et al.), pp. 716-756. Jones and Bartlett, Sudbury, MA.
2. Aguirre, A.J., Bardeesy, N., Sinha, M., Lopez, L., Tuveson, D.A., Horner, J., Redston, M.S., and DePinho, R.A. 2003. Activated Kras and Ink4a/Arf deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma. Genes & Dev. 17: 3112-3126
3. Arf-p53 in the suppression of murine pancreatic neoplasia. Mol. Cell. Biol. 22: 635-643.
4. Bardeesy, N., Cheng, K.-h., Berger, J.H., Chu, G.C., Pahler, J., Olson, P., Hezel, A.F., Horner, J., Lauwers, G.Y., Hanahan, D., et al. 2006. Smad4 is dispensable for normal pancreas development yet critical in progression and tumor biology of pancreas cancer. Genes & Dev. (this issue).
5. Berman, D.M., Karhadkar, S.S., Maitra, A., Montes De Oca, R., Gerstenblith, M.R., Briggs, K., Parker, A.R., Shimada, Y., Eshleman, J.R., Watkins, D.N., et al. 2003. Widespread requirement for Hedgehog ligand stimulation in growth of digestive tract tumours. Nature 425: 846-851.
6. V143A in promoting pancreatic cell migration, invasion, and tissue architecture disruption. Mol. Cell. Biol. 26: 4185-4200.
7. Derynck, R., Akhurst, R.J., and Balmain, A. 2001. TGF-β signaling in tumor suppression and cancer progression. Nat. Genet. 29: 117-129.
8. Grippo, P.J. and Sandgren, E.P. 2005. Modeling pancreatic cancer in animals to address specific hypotheses. Methods Mol. Med. 103: 217-243.
9. Hahn, S.A., Schutte, M., Hoque, A.T., Moskaluk, C.A., da Costa, L.T., Rozenblum, E., Weinstein, C.L., Fischer, A., Yeo, C.J., Hruban, R.H., et al. 1996. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science 271: 350-353.
10. Hanahan, D. 1985. Heritable formation of pancreatic β-cell tumours in transgenic mice expressing recombinant insulin/simian virus 40 oncogenes. Nature 315: 115-122.
11. Hansel, D.E., Kern, S.E., and Hruban, R.H. 2003. Molecular pathogenesis of pancreatic cancer. Annu. Rev. Genomics Hum. Genet. 4: 237-256.
12. Hezel, A.F., Kimmelman, A.C., Stanger, B.Z., Bardeesy, N., and Depinho, R.A. 2006. Genetics and biology of pancreatic ductal adenocarcinoma. Genes & Dev. 20: 1218-1249.
13. Hingorani, S.R., Petricoin, E.F., Maitra, A., Rajapakse, V., King, C., Jacobetz, M.A., Ross, S., Conrads, T.P., Veenstra, T.D., Hitt, B.A., et al. 2003. Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse. Cancer Cell 4: 437-450.
14. G12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice. Cancer Cell 7: 469-483.
15. Hruban, R.H. 2006. Tumors of the pancreas. In Atlas of tumor pathology (eds. R.H. Hruban et al.). Armed Forces Institute of Pathology, Washington, DC.
16. Hruban, R.H., Wilentz, R.E., and Kern, S.E. 2000. Genetic progression in the pancreatic ducts. Am. J. Pathol. 156: 1821-1825.
17. Hruban, R.H., Adsay, N.V., Albores-Saavedra, J., Compton, C., Garrett, E.S., Goodman, S.N., Kern, S.E., Klimstra, D.S., Kloppel, G., Longnecker, D.S., et al. 2001. Pancreatic intraepithelial neoplasia: A new nomenclature and classification system for pancreatic duct lesions. Am. J. Surg. Pathol. 25: 579-586.
18. Ijichi, H., Chytil, A., Gorska, A.E., Aakre, M.E., Fujitani, Y., Fujitani, S., Wright, C.V.E., and Moses, H.L. 2006. Aggressive pancreatic ductal adenocarcinoma in mice caused by pancreas-specific blockade of transforming growth factor-β signaling in cooperation with active Kras expression. Genes & Dev. (this issue).
19. Jemal, A., Tiwari, R.C., Murray, T., Ghafoor, A., Samuels, A., Ward, E., Feuer, E.J., and Thun, M.J. 2004. Cancer statistics, 2004. CA Cancer J. Clin. 54: 8-29.
20. Kawaguchi, Y., Cooper, B., Gannon, M., Ray, M., MacDonald, R.J., and Wright, C.V. 2002. The role of the transcriptional regulator Ptf1a in converting intestinal to pancreatic progenitors. Nat. Genet. 32: 128-134.
21. Kim, S.K. and MacDonald, R.J. 2002. Signaling and transcriptional control of pancreatic organogenesis. Curr. Opin. Genet. Dev. 12: 540-547.
22. Krapp, A., Knofler, M., Ledermann, B., Burki, K., Berney, C., Zoerkler, N., Hagenbuchle, O., and Wellauer, P.K. 1998. The bHLH protein PTF1-p48 is essential for the formation of the exocrine and the correct spatial organization of the endocrine pancreas. Genes & Dev. 12: 3752-3763.
23. Miyamoto, Y., Maitra, A., Ghosh, B., Zechner, U., Argani, P., Iacobuzio-Donahue, C.A., Sriuranpong, V., Iso, T., Meszoely, I.M., Wolfe, M.S., et al. 2003. Notch mediates TGF α-induced changes in epithelial differentiation during pancreatic tumorigenesis. Cancer Cell 3: 565-576.
24. Offield, M.F., Jetton, T.L., Labosky, P.A., Ray, M., Stein, R.W., Magnuson, M.A., Hogan, B.L., and Wright, C.V. 1996. PDX-1 is required for pancreatic outgrowth and differentiation of the rostral duodenum. Development 122: 983-995.
25. Pasca di Magliano, M., Sekine, S., Ermilov, A., Ferris, J., Dlugosz, A.A., and Hebrok, M. 2006. Hedgehog/Ras interactions regulate early stages of pancreatic cancer. Genes & Dev. (this issue).
26. Siegel, P.M. and Massague, J. 2003. Cytostatic and apoptotic actions of TGF-β in homeostasis and cancer. Nat. Rev. Cancer 3: 807-821.
27. Stanger, B.Z., Stiles, B., Lauwers, G.Y., Bardeesy, N., Mendoza, M., Wang, Y., Greenwood, A., Cheng, K.H., McLaughlin, M., Brown, D., et al. 2005. Pten constrains centroacinar cell expansion and malignant transformation in the pancreas. Cancer Cell 8: 185-195.
28. Tanaka, M., Chari, S., Adsay, V., Fernandez-del Castillo, C., Falconi, M., Shimizu, M., Yamaguchi, K., Yamao, K., and Matsuno, S. 2006. International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas. Pancreatol. 6: 17-32.
29. Thayer, S.P., di Magliano, M.P., Heiser, P.W., Nielsen, C.M., Roberts, D.J., Lauwers, G.Y., Qi, Y.P., Gysin, S., Fernandez-del Castillo, C., Yajnik, V., et al. 2003. Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis. Nature 425: 851-856.
30. Venkatasubbarao, K., Ahmed, M.M., Mohiuddin, M., Swiderski, C., Lee, E., Gower Jr., W.R., Salhab, K.F., McGrath, P., Strodel, W., and Freeman, J.W. 2000. Differential expression of transforming growth factor β receptors in human pancreatic adenocarcinoma. Anticancer Res. 20: 43-51.
31. Wagner, M., Luhrs, H., Kloppel, G., Adler, G., and Schmid, R.M. 1998. Malignant transformation of duct-like cells originating from acini in transforming growth factor transgenic mice. Gastroenterology 115: 1254-1262.
32. Wagner, M., Greten, F.R., Weber, C.K., Koschnick, S., Mattfeldt, T., Deppert, W., Kern, H., Adler, G., and Schmid, R.M. 2001. A murine tumor progression model for pancreatic cancer recapitulating the genetic alterations of the human disease. Genes & Dev. 15: 286-293.
33. Warshaw, A.L. and Fernandez-del Castillo, C. 1992. Pancreatic carcinoma. N. Engl. J. Med. 326: 455-465.